Disgraced stem-cell entrepreneur under fresh investigation
By Alison Abbott,
Nature News
| 11. 14. 2016
Davide Vannoni is barred from offering a controversial stem-cell therapy in Italy but may be continuing his work abroad.
Public prosecutors in Turin, Italy, are investigating whether disgraced stem-cell entrepreneur Davide Vannoni — convicted on criminal charges last year for administering unproven stem-cell therapies in Italy — is offering his treatments again, this time in eastern Europe.
In March 2015, Vannoni was convicted on charges of conspiracy and fraud related to his treatments, which had been declared dangerous by the Italian Health Authority (AIFA). His case was a cause célèbre among Italian scientists, who fought for many years to stop him administering stem cells to patients through his Stamina Foundation (see Nature 518, 455; 2015).
Vannoni was sentenced to 22 months in prison, but the sentence was suspended in a plea bargain drawn up by prosecutor Raffaele Guariniello, who said that the terms required Vannoni to refrain from organizing further therapies — either in Italy or abroad. Soon after the plea bargain, patient groups on social media posted comments that the stem-cell treatment was available once more, in Georgia. And in late October, a patient came...
Related Articles
By Tory Shepherd, The Guardian | 07.17.2026
Over eight years, Ethan and his wife went through nine rounds of IVF in Melbourne.
They travelled to Spain for two more, without success.
“I thought maybe the universe had decided we’re not supposed to have kids,” says Ethan, who...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
